Correlation Between Zura Bio and Pyxis Oncology

Can any of the company-specific risk be diversified away by investing in both Zura Bio and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zura Bio Limited and Pyxis Oncology, you can compare the effects of market volatilities on Zura Bio and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Pyxis Oncology.

Diversification Opportunities for Zura Bio and Pyxis Oncology

0.87

Correlation Coefficient

Zura Bio  Pyxis Oncology

Very poor diversification

The 3 months correlation between Zura and Pyxis is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Zura Bio i.e., Zura Bio and Pyxis Oncology go up and down completely randomly.

Pair Corralation between Zura Bio and Pyxis Oncology

Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the Pyxis Oncology. In addition to that, Zura Bio is 1.5 times more volatile than Pyxis Oncology. It trades about -0.14 of its total potential returns per unit of risk. Pyxis Oncology is currently generating about -0.15 per unit of volatility. If you would invest  159.00  in Pyxis Oncology on December 27, 2024 and sell it today you would lose (54.00) from holding Pyxis Oncology or give up 33.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Zura Bio Limited  vs.  Pyxis Oncology

Zura Bio Limited

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pyxis Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pyxis Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Zura Bio and Pyxis Oncology

The main advantage of trading using opposite Zura Bio and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.

The idea behind Zura Bio Limited and Pyxis Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.